Slc35a3 | solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member 3
Physiological systems
17 / 24 physiological systems tested
6 Significantly impacted by the knock-out
Embryo Growth/size/body region Digestive/alimentary Limbs/digits/tail Craniofacial Mortality/aging
11 No significant impact
7 Not tested
Data collections
Gene metrics:5Significant phenotypes
2Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
abnormal tail morphology | 2 supporting datasets | Slc35a3em1(IMPC)Bay | homozygote | E18.5 | N/A * | ||
preweaning lethality, complete penetrance | 3 supporting datasets | Slc35a3em1(IMPC)Bay | homozygote | Early adult | N/A * | ||
abnormal body wall morphology | 1 supporting dataset | Slc35a3em1(IMPC)Bay | homozygote | E18.5 | N/A * | ||
abnormal embryo size | 1 supporting dataset | Slc35a3em1(IMPC)Bay | homozygote | E18.5 | N/A * | ||
protruding tongue | 1 supporting dataset | Slc35a3em1(IMPC)Bay | homozygote | E18.5 | N/A * |
| | | | | | | | | |
External links
No external links available for Slc35a3.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.